1. Home >
  2. M&A >
  3. Growth Capital >
  4. United States >
  5. California >
  6. Meiji Invests In Lyric Bio

Investment Summary

Meiji Invests In Lyric Bio

On December 4, 2025, Meiji invested in life science company Lyric Bio

Investment Highlights
  • This is Meiji’s 2nd transaction in the Life Science sector.
  • This is Meiji’s 1st transaction in the United States.
  • This is Meiji’s 1st transaction in California.

Investment Summary
Date 2025-12-04
Target Lyric Bio
Sector Life Science
Investor(s) Meiji
Deal Type Growth Capital

Target

Lyric Bio

San Francisco, California, United States
Lyric Bio manufactures donor-derived and protein-based therapeutics, with an initial focus on immunoglobulin production. By leveraging proprietary tissue engineering technologies, it aims to end chronic shortages, reduce costs, and improve global drug access for life-saving medicines. Lyric Bio is based in San Francisco, California.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Meiji

Tokyo , Japan
Category Company
Founded 1946
Sector Life Science
DESCRIPTION

Meiji is providing efficacious and high-quality pharmaceutical products including therapeutics and vaccines for infectious diseases, therapeutics for central nervous system diseases and generic drugs, to meet various medical needs. Meiji was founded in 1946 and is based in Tokyo, Japan.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Growth Capital M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-14 ARCALIS

Fukushima , Japan

ARCALIS is an mRNA vaccines and therapeutics contract development and manufacturing organization (“CDMO”), jointly established by Axcelead, Inc. and Arcturus Therapeutics, Inc. ARCALIS was formed in 2021 and is based in Fukushima, Japan.

Buy -
Mergr

Solution for

Product

Company

Legal